InsidersTradesSigma
Follow the 方盛制药 stock price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 方盛制药 has recorded 10 reports. Market capitalisation: €4.1bn. The latest transaction was disclosed on 13 May 2025 (Purchase). Among the most active insiders: 何仕. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
10 of 10 declarations
Fangsheng Pharmaceutical is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and production of innovative medicines.